Back
AbbVie, Inc. Stock Price Chart
This Critical Mineral's Up 122% in the Last 12 Months.
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
62
ABBV
AbbVie, Inc.
Last Price:
$223.73
Seasonality Move:
5.27%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ABBV is experiencing slight buying pressure.
AbbVie, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 221.62 | Buy |
| 20-day SMA: | 219.95 | Buy |
| 50-day SMA: | 224.02 | Sell |
| 200-day SMA: | 209.64 | Buy |
| 8-day EMA: | 221.42 | Buy |
| 20-day EMA: | 221.56 | Buy |
| 50-day EMA: | 222.87 | Buy |
| 200-day EMA: | 212.95 | Buy |
AbbVie, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.63 | Sell |
| Relative Strength Index (14 RSI): | 51.87 | Buy |
| Chaikin Money Flow: | 2105196 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (216.84 - 225.56) | Buy |
| Bollinger Bands (100): | (219.69 - 231.31) | Sell |
AbbVie, Inc. Technical Analysis
| Jan 26 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 26 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for AbbVie, Inc. Stock
Is AbbVie, Inc. Stock a Buy?
-
AbbVie, Inc. share price is 223.43 while ABBV 8-day simple moving average is 221.62, which is a Buy signal.
-
The stock price of ABBV is 223.43 while AbbVie, Inc. 20-day SMA is 219.95, which makes it a Buy.
-
AbbVie, Inc. 50-day simple moving average is 224.02 while ABBV share price is 223.43, making it a Sell technically.
-
ABBV stock price is 223.43 and AbbVie, Inc. 200-day simple moving average is 209.64, creating a Buy signal.
ABBV Technical Analysis vs Fundamental Analysis
Buy
62
AbbVie, Inc. (ABBV)
is a Buy
Is AbbVie, Inc. a Buy or a Sell?
-
AbbVie, Inc. stock is rated a BuyThe current AbbVie, Inc. [ABBV] share price is $223.43. The Score for ABBV is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
AbbVie, Inc. Stock Info
Market Cap:
394.9B
Price in USD:
223.43
Share Volume:
6.1M
AbbVie, Inc. 52-Week Range
52-Week High:
244.81
52-Week Low:
164.39
Buy
62
AbbVie, Inc. (ABBV)
is a Buy
AbbVie, Inc. Share Price Forecast
-
What is the AbbVie, Inc. stock price today?The AbbVie, Inc. stock price is 223.43 USD today.
-
Will ABBV stock go up or go down?AbbVie, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is AbbVie, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, AbbVie, Inc. is not overvalued.
Is AbbVie, Inc. Stock a Buy?
-
AbbVie, Inc. share price is 223.43 while ABBV 8-day exponential moving average is 221.42, which is a Buy signal.
-
The stock price of ABBV is 223.43 while AbbVie, Inc. 20-day EMA is 221.56, which makes it a Buy.
-
AbbVie, Inc. 50-day exponential moving average is 222.87 while ABBV share price is 223.43, making it a Buy technically.
-
ABBV stock price is 223.43 and AbbVie, Inc. 200-day simple moving average is 212.95, creating a Buy signal.
Fundamental Analysis of AbbVie, Inc.
Is AbbVie, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $1.43 per share, a decrease next quarter of $0.59 per share, an increase this year of $4.63 per share, and an increase next year of $1.42 per share.
Technical Analysis of AbbVie, Inc.
Should I short AbbVie, Inc. stock?
-
ABBV Moving Average Covergence Divergence (MACD) indicator is -0.63, suggesting AbbVie, Inc. is a Sell
-
AbbVie, Inc. Relative Strength Index (RSI) is 51.87, which suggest AbbVie, Inc. is overbought
-
The Bollinger Bands (25) for AbbVie, Inc. is (216.84 - 225.56), which suggest AbbVie, Inc. is a Sell
-
The Bollinger Bands (100) for AbbVie, Inc. is (219.69 - 231.31), which suggest AbbVie, Inc. is a Sell
* AbbVie, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.